Determining the Factors Predicting the Success of Medical Management in Patients with Ectopic Pregnancy : Medical management in patients with ectopic pregnancy.

IF 0.6 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Galen Medical Journal Pub Date : 2025-06-29 eCollection Date: 2025-01-01 DOI:10.31661/gmj.vi.3761
Ayda Roostaee, Zeinab Safarpour Lima, Sima Sharif Kazemi, Ghazaleh Dezyani, Seyed Taleb Pourseyedian
{"title":"Determining the Factors Predicting the Success of Medical Management in Patients with Ectopic Pregnancy : Medical management in patients with ectopic pregnancy.","authors":"Ayda Roostaee, Zeinab Safarpour Lima, Sima Sharif Kazemi, Ghazaleh Dezyani, Seyed Taleb Pourseyedian","doi":"10.31661/gmj.vi.3761","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ectopic pregnancy is considered the most common cause of pregnancy-related deaths in the first trimester. Methotrexate is recognized as an effective drug for the treatment of ectopic pregnancy. The aim of this study was to determine the associated and predictive factors for success in medical treatment among patients with ectopic pregnancy (EP).</p><p><strong>Materials and methods: </strong>After collection of Demographic information, serum β-hCG levels and ultrasound findings were evaluated and compared between two groups: those with successful medical treatment and those without.</p><p><strong>Results: </strong>The mean β-hCG level have not significant difference between the two groups (P=0.806). The frequency of previous IUD use in the successful treatment group was 8%, while there were no cases in the failure group; however, this difference was not statistically significant (P=0.547). The frequency of prior EP, the observed frequency of hematoma and the frequency of tubal ring observation, which also showed no significant difference (respectively P=0.9, P=0.9 and P=0.111). Logistic regression analysis revealed that none of the investigated variables were significant predictors of treatment success. However, the presence of a tubal ring (OR: 6.500, 95% CI: 0.799-52.897, p = 0.080) and increased endometrial thickness (OR: 1.317, 95% CI: 0.971-1.786, p = 0.077) showed borderline significance. Commonly considered factors, such as gestational age, β-hCG levels, patient age, parity, and gravidity, did not significantly influence treatment success. The study highlights a high success rate for single-dose methotrexate therapy and the potential utility of tubal ring and endometrial thickness as clinical indicators, warranting further investigation.</p><p><strong>Conclusion: </strong>The results of this study indicate that single-dose methotrexate treatment for tubal ectopic pregnancy leads to a high success rate. Given the sample size of this study, none of the variables had a significant impact on treatment success or predictive power.</p>","PeriodicalId":44017,"journal":{"name":"Galen Medical Journal","volume":"14 ","pages":"e3761"},"PeriodicalIF":0.6000,"publicationDate":"2025-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311627/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Galen Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31661/gmj.vi.3761","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Ectopic pregnancy is considered the most common cause of pregnancy-related deaths in the first trimester. Methotrexate is recognized as an effective drug for the treatment of ectopic pregnancy. The aim of this study was to determine the associated and predictive factors for success in medical treatment among patients with ectopic pregnancy (EP).

Materials and methods: After collection of Demographic information, serum β-hCG levels and ultrasound findings were evaluated and compared between two groups: those with successful medical treatment and those without.

Results: The mean β-hCG level have not significant difference between the two groups (P=0.806). The frequency of previous IUD use in the successful treatment group was 8%, while there were no cases in the failure group; however, this difference was not statistically significant (P=0.547). The frequency of prior EP, the observed frequency of hematoma and the frequency of tubal ring observation, which also showed no significant difference (respectively P=0.9, P=0.9 and P=0.111). Logistic regression analysis revealed that none of the investigated variables were significant predictors of treatment success. However, the presence of a tubal ring (OR: 6.500, 95% CI: 0.799-52.897, p = 0.080) and increased endometrial thickness (OR: 1.317, 95% CI: 0.971-1.786, p = 0.077) showed borderline significance. Commonly considered factors, such as gestational age, β-hCG levels, patient age, parity, and gravidity, did not significantly influence treatment success. The study highlights a high success rate for single-dose methotrexate therapy and the potential utility of tubal ring and endometrial thickness as clinical indicators, warranting further investigation.

Conclusion: The results of this study indicate that single-dose methotrexate treatment for tubal ectopic pregnancy leads to a high success rate. Given the sample size of this study, none of the variables had a significant impact on treatment success or predictive power.

确定预测异位妊娠患者医疗管理成功的因素:异位妊娠患者的医疗管理。
背景:异位妊娠被认为是妊娠早期死亡的最常见原因。甲氨蝶呤是公认的治疗异位妊娠的有效药物。本研究的目的是确定异位妊娠(EP)患者药物治疗成功的相关因素和预测因素。材料与方法:收集人口统计学信息后,评价和比较治疗成功组和治疗失败组的血清β-hCG水平和超声检查结果。结果:两组间平均β-hCG水平差异无统计学意义(P=0.806)。治疗成功组既往使用宫内节育器的频率为8%,治疗失败组无一例;但差异无统计学意义(P=0.547)。既往EP频次、血肿观察频次、管环观察频次差异无统计学意义(P=0.9、P=0.9、P=0.111)。逻辑回归分析显示,所调查的变量中没有一个是治疗成功的显著预测因子。然而,输卵管环的存在(OR: 6.500, 95% CI: 0.799-52.897, p = 0.080)和子宫内膜厚度的增加(OR: 1.317, 95% CI: 0.971-1.786, p = 0.077)具有临界意义。通常考虑的因素,如胎龄、β-hCG水平、患者年龄、胎次和妊娠对治疗成功没有显著影响。该研究强调了单剂量甲氨蝶呤治疗的高成功率以及输卵管环和子宫内膜厚度作为临床指标的潜在效用,值得进一步研究。结论:单剂量甲氨蝶呤治疗输卵管异位妊娠成功率高。考虑到本研究的样本量,没有一个变量对治疗成功或预测能力有显著影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Galen Medical Journal
Galen Medical Journal MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
13
期刊介绍: GMJ is open access, peer-reviewed journal in English and supported by Noncommunicable Diseases (NCD) Research Center of Fasa University of Medical Sciences that publishing by Salvia Medical Sciences Ltd. GMJ will consider all types of the following scientific papers for publication: - Editorial’s choice - Original Researches - Review articles - Case reports - Case series - Letter (to editors, to authors, etc) - Short communications - Medical Idea
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书